Development and evaluation of Radical Oxygen Species (ROS)-responsive drug delivery systems to prevent and cure inflammatory and hypoxic diseases.

Informazioni relative al progetto

ROSCURE-O2

ID dell’accordo di sovvenzione: 101153515

DOI

10.3030/101153515

Progetto chiuso

Data della firma CE 17 Aprile 2024

Data di avvio 1 Settembre 2024

Data di completamento 31 Agosto 2026

Finanziato da

• Marie Skłodowska-Curie Actions (MSCA)

Costo totale

Nessun dato

Contributo UE

€ 165 312,96

Coordinato da

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
Spain

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Data Management Plan (1)

Data Management Plan

The Data Management Plan describes the data management life cycle for all data sets that will be collected, processed or generated by the action. It is a document describing what data will be collected, processed or generated and following what methodology and standards, whether and how this data will be shared and/or made open, and how it will be curated and preserved.

Documents, reports (1)

Communication, Dissemination & Exploitation Plan

The plan describes the planned measures to maximize the impact of the project, including the dissemination and exploitation measures that are planned, and the target group(s) addressed. Regarding communication measures and public engagement strategy, the aim is to inform and reach out to society and show the activities performed, and the use and the benefits the project will have for citizens.

Pubblicazioni

Peer reviewed articles (3)

Extracellular matrix remodeling therapeutic strategies to tackle central nervous system diseases

Autori: Daniel A. Domingo-Lopez, Maria Rosa Aguilar de Armas, Sergio Martin-Saldaña
Pubblicato in: Neural Regeneration Research, Numero 21, 2026, ISSN 1673-5374
Editore: Ovid Technologies (Wolters Kluwer Health)
DOI: 10.4103/NRR.NRR-D-25-01562

Viologen redox polymers for NADH-free alcohol dehydrogenase bioelectrocatalysis: Structure–activity relationships and mechanistic insight

Autori: Kavita Jayakumar, Mihai-Cristian Fera, P.Yeray Pernia-Blazquez, Daniel A. Domingo-Lopez, Antonio L. De Lacey's, Marcos Pita
Pubblicato in: Electrochimica Acta, Numero 577, 2026, ISSN 0013-4686
Editore: Elsevier BV
DOI: 10.1016/J.ELECTACTA.2026.149736

From cold chain to ambient: Benefits, risks, and evidence across cell therapy logistics

Autori: John Gostage, Daniel A. Domingo-Lopez, Ruth Tarpey, Garry P. Duffy, Ruth E. Levey
Pubblicato in: Molecular Therapy Methods & Clinical Development, Numero 33, 2026, ISSN 2329-0501
Editore: Elsevier BV
DOI: 10.1016/J.OMTM.2025.101613

Book chapters (1)

Osteochondral Angiogenesis and Promoted Vascularization: New Therapeutic Target

Autori: Daniel A. Domingo-Lopez, Luis García-Fernández
Pubblicato in: Osteochondral Tissue Engineering, 2026
Editore: Springer Nature Switzerland
DOI: 10.1007/978-3-031-80976-7_14-1